Global Infectious Disease Point of Care Diagnostics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Infectious Disease Point of Care Diagnostics market size will reach US$ million by 2031.
Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Infectious Disease Point of Care Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Disease Point of Care Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Point of Care Diagnostics sales for 2025 through 2031. With Infectious Disease Point of Care Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Point of Care Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease Point of Care Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Point of Care Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Point of Care Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Point of Care Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Point of Care Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Point of Care Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Infectious Disease Point of Care Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Disease Point of Care Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Point of Care Diagnostics sales for 2025 through 2031. With Infectious Disease Point of Care Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Point of Care Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease Point of Care Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Point of Care Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Point of Care Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Point of Care Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Point of Care Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Point of Care Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Over-the-counter (OTC) Testing Kits
- Prescription-based Testing Kits
- Bacterial Infections
- Fungal Infection
- Virus Infection
- Cardiovascular Infection
- Gastrointestinal Infection
- Sexually Transmitted Disease (STD) Infection
- Central Nervous System Infection
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- Euroimmun
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Point of Care Diagnostics Market Size (2020-2031)
2.1.2 Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Infectious Disease Point of Care Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Infectious Disease Point of Care Diagnostics Segment by Type
2.2.1 Over-the-counter (OTC) Testing Kits
2.2.2 Prescription-based Testing Kits
2.3 Infectious Disease Point of Care Diagnostics Market Size by Type
2.3.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Infectious Disease Point of Care Diagnostics Segment by Application
2.4.1 Bacterial Infections
2.4.2 Fungal Infection
2.4.3 Virus Infection
2.4.4 Cardiovascular Infection
2.4.5 Gastrointestinal Infection
2.4.6 Sexually Transmitted Disease (STD) Infection
2.4.7 Central Nervous System Infection
2.4.8 Other
2.5 Infectious Disease Point of Care Diagnostics Market Size by Application
2.5.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
3 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease Point of Care Diagnostics Market Size Market Share by Player
3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BY REGION
4.1 Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025)
4.2 Global Infectious Disease Point of Care Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.4 APAC Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.5 Europe Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025)
5.2 Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
5.3 Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025)
6.2 APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
6.3 APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Point of Care Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Infectious Disease Point of Care Diagnostics Forecast
10.1.3 APAC Infectious Disease Point of Care Diagnostics Forecast
10.1.4 Europe Infectious Disease Point of Care Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast
10.2 Americas Infectious Disease Point of Care Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Infectious Disease Point of Care Diagnostics Forecast
10.2.2 Canada Market Infectious Disease Point of Care Diagnostics Forecast
10.2.3 Mexico Market Infectious Disease Point of Care Diagnostics Forecast
10.2.4 Brazil Market Infectious Disease Point of Care Diagnostics Forecast
10.3 APAC Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.3.1 China Infectious Disease Point of Care Diagnostics Market Forecast
10.3.2 Japan Market Infectious Disease Point of Care Diagnostics Forecast
10.3.3 Korea Market Infectious Disease Point of Care Diagnostics Forecast
10.3.4 Southeast Asia Market Infectious Disease Point of Care Diagnostics Forecast
10.3.5 India Market Infectious Disease Point of Care Diagnostics Forecast
10.3.6 Australia Market Infectious Disease Point of Care Diagnostics Forecast
10.4 Europe Infectious Disease Point of Care Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Infectious Disease Point of Care Diagnostics Forecast
10.4.2 France Market Infectious Disease Point of Care Diagnostics Forecast
10.4.3 UK Market Infectious Disease Point of Care Diagnostics Forecast
10.4.4 Italy Market Infectious Disease Point of Care Diagnostics Forecast
10.4.5 Russia Market Infectious Disease Point of Care Diagnostics Forecast
10.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Infectious Disease Point of Care Diagnostics Forecast
10.5.2 South Africa Market Infectious Disease Point of Care Diagnostics Forecast
10.5.3 Israel Market Infectious Disease Point of Care Diagnostics Forecast
10.5.4 Turkey Market Infectious Disease Point of Care Diagnostics Forecast
10.6 Global Infectious Disease Point of Care Diagnostics Forecast by Type (2026-2031)
10.7 Global Infectious Disease Point of Care Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Infectious Disease Point of Care Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Disease Point of Care Diagnostics Product Offered
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Siemens
11.2.1 Siemens Company Information
11.2.2 Siemens Infectious Disease Point of Care Diagnostics Product Offered
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Siemens Main Business Overview
11.2.5 Siemens Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Accriva
11.4.1 Accriva Company Information
11.4.2 Accriva Infectious Disease Point of Care Diagnostics Product Offered
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Accriva Main Business Overview
11.4.5 Accriva Latest Developments
11.5 Terumo
11.5.1 Terumo Company Information
11.5.2 Terumo Infectious Disease Point of Care Diagnostics Product Offered
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Terumo Main Business Overview
11.5.5 Terumo Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Diasorin
11.7.1 Diasorin Company Information
11.7.2 Diasorin Infectious Disease Point of Care Diagnostics Product Offered
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Diasorin Main Business Overview
11.7.5 Diasorin Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Infectious Disease Point of Care Diagnostics Product Offered
11.8.3 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Information
11.9.2 Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Danaher Corporation Main Business Overview
11.9.5 Danaher Corporation Latest Developments
11.10 BD
11.10.1 BD Company Information
11.10.2 BD Infectious Disease Point of Care Diagnostics Product Offered
11.10.3 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 BD Main Business Overview
11.10.5 BD Latest Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Information
11.11.2 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bio-Rad Laboratories Main Business Overview
11.11.5 Bio-Rad Laboratories Latest Developments
11.12 Cavidi
11.12.1 Cavidi Company Information
11.12.2 Cavidi Infectious Disease Point of Care Diagnostics Product Offered
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cavidi Main Business Overview
11.12.5 Cavidi Latest Developments
11.13 Cepheid
11.13.1 Cepheid Company Information
11.13.2 Cepheid Infectious Disease Point of Care Diagnostics Product Offered
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cepheid Main Business Overview
11.13.5 Cepheid Latest Developments
11.14 Diaxonhit
11.14.1 Diaxonhit Company Information
11.14.2 Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Diaxonhit Main Business Overview
11.14.5 Diaxonhit Latest Developments
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Information
11.15.2 Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Eiken Chemical Main Business Overview
11.15.5 Eiken Chemical Latest Developments
11.16 EMD Millipore
11.16.1 EMD Millipore Company Information
11.16.2 EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 EMD Millipore Main Business Overview
11.16.5 EMD Millipore Latest Developments
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Information
11.17.2 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Epitope Diagnostic Main Business Overview
11.17.5 Epitope Diagnostic Latest Developments
11.18 Euroimmun
11.18.1 Euroimmun Company Information
11.18.2 Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Euroimmun Main Business Overview
11.18.5 Euroimmun Latest Developments
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Information
11.19.2 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Gold Standard Diagnostics Main Business Overview
11.19.5 Gold Standard Diagnostics Latest Developments
11.20 Hologic
11.20.1 Hologic Company Information
11.20.2 Hologic Infectious Disease Point of Care Diagnostics Product Offered
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hologic Main Business Overview
11.20.5 Hologic Latest Developments
11.21 Immunetics
11.21.1 Immunetics Company Information
11.21.2 Immunetics Infectious Disease Point of Care Diagnostics Product Offered
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Immunetics Main Business Overview
11.21.5 Immunetics Latest Developments
11.22 InBios International
11.22.1 InBios International Company Information
11.22.2 InBios International Infectious Disease Point of Care Diagnostics Product Offered
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 InBios International Main Business Overview
11.22.5 InBios International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Point of Care Diagnostics Market Size (2020-2031)
2.1.2 Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Infectious Disease Point of Care Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Infectious Disease Point of Care Diagnostics Segment by Type
2.2.1 Over-the-counter (OTC) Testing Kits
2.2.2 Prescription-based Testing Kits
2.3 Infectious Disease Point of Care Diagnostics Market Size by Type
2.3.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Infectious Disease Point of Care Diagnostics Segment by Application
2.4.1 Bacterial Infections
2.4.2 Fungal Infection
2.4.3 Virus Infection
2.4.4 Cardiovascular Infection
2.4.5 Gastrointestinal Infection
2.4.6 Sexually Transmitted Disease (STD) Infection
2.4.7 Central Nervous System Infection
2.4.8 Other
2.5 Infectious Disease Point of Care Diagnostics Market Size by Application
2.5.1 Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
3 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Infectious Disease Point of Care Diagnostics Market Size Market Share by Player
3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS BY REGION
4.1 Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025)
4.2 Global Infectious Disease Point of Care Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.4 APAC Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.5 Europe Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025)
5.2 Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
5.3 Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025)
6.2 APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
6.3 APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Point of Care Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET FORECAST
10.1 Global Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Infectious Disease Point of Care Diagnostics Forecast
10.1.3 APAC Infectious Disease Point of Care Diagnostics Forecast
10.1.4 Europe Infectious Disease Point of Care Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast
10.2 Americas Infectious Disease Point of Care Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Infectious Disease Point of Care Diagnostics Forecast
10.2.2 Canada Market Infectious Disease Point of Care Diagnostics Forecast
10.2.3 Mexico Market Infectious Disease Point of Care Diagnostics Forecast
10.2.4 Brazil Market Infectious Disease Point of Care Diagnostics Forecast
10.3 APAC Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.3.1 China Infectious Disease Point of Care Diagnostics Market Forecast
10.3.2 Japan Market Infectious Disease Point of Care Diagnostics Forecast
10.3.3 Korea Market Infectious Disease Point of Care Diagnostics Forecast
10.3.4 Southeast Asia Market Infectious Disease Point of Care Diagnostics Forecast
10.3.5 India Market Infectious Disease Point of Care Diagnostics Forecast
10.3.6 Australia Market Infectious Disease Point of Care Diagnostics Forecast
10.4 Europe Infectious Disease Point of Care Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Infectious Disease Point of Care Diagnostics Forecast
10.4.2 France Market Infectious Disease Point of Care Diagnostics Forecast
10.4.3 UK Market Infectious Disease Point of Care Diagnostics Forecast
10.4.4 Italy Market Infectious Disease Point of Care Diagnostics Forecast
10.4.5 Russia Market Infectious Disease Point of Care Diagnostics Forecast
10.5 Middle East & Africa Infectious Disease Point of Care Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Infectious Disease Point of Care Diagnostics Forecast
10.5.2 South Africa Market Infectious Disease Point of Care Diagnostics Forecast
10.5.3 Israel Market Infectious Disease Point of Care Diagnostics Forecast
10.5.4 Turkey Market Infectious Disease Point of Care Diagnostics Forecast
10.6 Global Infectious Disease Point of Care Diagnostics Forecast by Type (2026-2031)
10.7 Global Infectious Disease Point of Care Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Infectious Disease Point of Care Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Disease Point of Care Diagnostics Product Offered
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Siemens
11.2.1 Siemens Company Information
11.2.2 Siemens Infectious Disease Point of Care Diagnostics Product Offered
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Siemens Main Business Overview
11.2.5 Siemens Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Accriva
11.4.1 Accriva Company Information
11.4.2 Accriva Infectious Disease Point of Care Diagnostics Product Offered
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Accriva Main Business Overview
11.4.5 Accriva Latest Developments
11.5 Terumo
11.5.1 Terumo Company Information
11.5.2 Terumo Infectious Disease Point of Care Diagnostics Product Offered
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Terumo Main Business Overview
11.5.5 Terumo Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Diasorin
11.7.1 Diasorin Company Information
11.7.2 Diasorin Infectious Disease Point of Care Diagnostics Product Offered
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Diasorin Main Business Overview
11.7.5 Diasorin Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Infectious Disease Point of Care Diagnostics Product Offered
11.8.3 Roche Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Information
11.9.2 Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Danaher Corporation Main Business Overview
11.9.5 Danaher Corporation Latest Developments
11.10 BD
11.10.1 BD Company Information
11.10.2 BD Infectious Disease Point of Care Diagnostics Product Offered
11.10.3 BD Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 BD Main Business Overview
11.10.5 BD Latest Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Information
11.11.2 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bio-Rad Laboratories Main Business Overview
11.11.5 Bio-Rad Laboratories Latest Developments
11.12 Cavidi
11.12.1 Cavidi Company Information
11.12.2 Cavidi Infectious Disease Point of Care Diagnostics Product Offered
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cavidi Main Business Overview
11.12.5 Cavidi Latest Developments
11.13 Cepheid
11.13.1 Cepheid Company Information
11.13.2 Cepheid Infectious Disease Point of Care Diagnostics Product Offered
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cepheid Main Business Overview
11.13.5 Cepheid Latest Developments
11.14 Diaxonhit
11.14.1 Diaxonhit Company Information
11.14.2 Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Diaxonhit Main Business Overview
11.14.5 Diaxonhit Latest Developments
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Information
11.15.2 Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Eiken Chemical Main Business Overview
11.15.5 Eiken Chemical Latest Developments
11.16 EMD Millipore
11.16.1 EMD Millipore Company Information
11.16.2 EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 EMD Millipore Main Business Overview
11.16.5 EMD Millipore Latest Developments
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Information
11.17.2 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Epitope Diagnostic Main Business Overview
11.17.5 Epitope Diagnostic Latest Developments
11.18 Euroimmun
11.18.1 Euroimmun Company Information
11.18.2 Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Euroimmun Main Business Overview
11.18.5 Euroimmun Latest Developments
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Information
11.19.2 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Gold Standard Diagnostics Main Business Overview
11.19.5 Gold Standard Diagnostics Latest Developments
11.20 Hologic
11.20.1 Hologic Company Information
11.20.2 Hologic Infectious Disease Point of Care Diagnostics Product Offered
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hologic Main Business Overview
11.20.5 Hologic Latest Developments
11.21 Immunetics
11.21.1 Immunetics Company Information
11.21.2 Immunetics Infectious Disease Point of Care Diagnostics Product Offered
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Immunetics Main Business Overview
11.21.5 Immunetics Latest Developments
11.22 InBios International
11.22.1 InBios International Company Information
11.22.2 InBios International Infectious Disease Point of Care Diagnostics Product Offered
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 InBios International Main Business Overview
11.22.5 InBios International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infectious Disease Point of Care Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Over-the-counter (OTC) Testing Kits
Table 4. Major Players of Prescription-based Testing Kits
Table 5. Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Infectious Disease Point of Care Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
Table 14. Infectious Disease Point of Care Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Infectious Disease Point of Care Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Infectious Disease Point of Care Diagnostics
Table 39. Key Market Challenges & Risks of Infectious Disease Point of Care Diagnostics
Table 40. Key Industry Trends of Infectious Disease Point of Care Diagnostics
Table 41. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 46. Abbott Infectious Disease Point of Care Diagnostics Product Offered
Table 47. Abbott Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Main Business
Table 49. Abbott Latest Developments
Table 50. Siemens Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 51. Siemens Infectious Disease Point of Care Diagnostics Product Offered
Table 52. Siemens Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Siemens Main Business
Table 54. Siemens Latest Developments
Table 55. GE Healthcare Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 56. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
Table 57. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. GE Healthcare Main Business
Table 59. GE Healthcare Latest Developments
Table 60. Accriva Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 61. Accriva Infectious Disease Point of Care Diagnostics Product Offered
Table 62. Accriva Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Accriva Main Business
Table 64. Accriva Latest Developments
Table 65. Terumo Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 66. Terumo Infectious Disease Point of Care Diagnostics Product Offered
Table 67. Terumo Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Terumo Main Business
Table 69. Terumo Latest Developments
Table 70. BioMerieux Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 71. BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
Table 72. BioMerieux Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioMerieux Main Business
Table 74. BioMerieux Latest Developments
Table 75. Diasorin Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 76. Diasorin Infectious Disease Point of Care Diagnostics Product Offered
Table 77. Diasorin Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Diasorin Main Business
Table 79. Diasorin Latest Developments
Table 80. Roche Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 81. Roche Infectious Disease Point of Care Diagnostics Product Offered
Table 82. Roche Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Danaher Corporation Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 86. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
Table 87. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Danaher Corporation Main Business
Table 89. Danaher Corporation Latest Developments
Table 90. BD Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 91. BD Infectious Disease Point of Care Diagnostics Product Offered
Table 92. BD Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. BD Main Business
Table 94. BD Latest Developments
Table 95. Bio-Rad Laboratories Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 96. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
Table 97. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Bio-Rad Laboratories Main Business
Table 99. Bio-Rad Laboratories Latest Developments
Table 100. Cavidi Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 101. Cavidi Infectious Disease Point of Care Diagnostics Product Offered
Table 102. Cavidi Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Cavidi Main Business
Table 104. Cavidi Latest Developments
Table 105. Cepheid Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 106. Cepheid Infectious Disease Point of Care Diagnostics Product Offered
Table 107. Cepheid Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cepheid Main Business
Table 109. Cepheid Latest Developments
Table 110. Diaxonhit Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 111. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
Table 112. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Diaxonhit Main Business
Table 114. Diaxonhit Latest Developments
Table 115. Eiken Chemical Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 116. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
Table 117. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Eiken Chemical Main Business
Table 119. Eiken Chemical Latest Developments
Table 120. EMD Millipore Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 121. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
Table 122. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. EMD Millipore Main Business
Table 124. EMD Millipore Latest Developments
Table 125. Epitope Diagnostic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 126. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
Table 127. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Epitope Diagnostic Main Business
Table 129. Epitope Diagnostic Latest Developments
Table 130. Euroimmun Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 131. Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
Table 132. Euroimmun Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Euroimmun Main Business
Table 134. Euroimmun Latest Developments
Table 135. Gold Standard Diagnostics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 136. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
Table 137. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Gold Standard Diagnostics Main Business
Table 139. Gold Standard Diagnostics Latest Developments
Table 140. Hologic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 141. Hologic Infectious Disease Point of Care Diagnostics Product Offered
Table 142. Hologic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hologic Main Business
Table 144. Hologic Latest Developments
Table 145. Immunetics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 146. Immunetics Infectious Disease Point of Care Diagnostics Product Offered
Table 147. Immunetics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Immunetics Main Business
Table 149. Immunetics Latest Developments
Table 150. InBios International Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 151. InBios International Infectious Disease Point of Care Diagnostics Product Offered
Table 152. InBios International Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. InBios International Main Business
Table 154. InBios International Latest Developments
Table 1. Infectious Disease Point of Care Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Infectious Disease Point of Care Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Over-the-counter (OTC) Testing Kits
Table 4. Major Players of Prescription-based Testing Kits
Table 5. Infectious Disease Point of Care Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Infectious Disease Point of Care Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Infectious Disease Point of Care Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Infectious Disease Point of Care Diagnostics Key Players Head office and Products Offered
Table 14. Infectious Disease Point of Care Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Infectious Disease Point of Care Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Infectious Disease Point of Care Diagnostics
Table 39. Key Market Challenges & Risks of Infectious Disease Point of Care Diagnostics
Table 40. Key Industry Trends of Infectious Disease Point of Care Diagnostics
Table 41. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 46. Abbott Infectious Disease Point of Care Diagnostics Product Offered
Table 47. Abbott Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Main Business
Table 49. Abbott Latest Developments
Table 50. Siemens Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 51. Siemens Infectious Disease Point of Care Diagnostics Product Offered
Table 52. Siemens Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Siemens Main Business
Table 54. Siemens Latest Developments
Table 55. GE Healthcare Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 56. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offered
Table 57. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. GE Healthcare Main Business
Table 59. GE Healthcare Latest Developments
Table 60. Accriva Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 61. Accriva Infectious Disease Point of Care Diagnostics Product Offered
Table 62. Accriva Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Accriva Main Business
Table 64. Accriva Latest Developments
Table 65. Terumo Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 66. Terumo Infectious Disease Point of Care Diagnostics Product Offered
Table 67. Terumo Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Terumo Main Business
Table 69. Terumo Latest Developments
Table 70. BioMerieux Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 71. BioMerieux Infectious Disease Point of Care Diagnostics Product Offered
Table 72. BioMerieux Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BioMerieux Main Business
Table 74. BioMerieux Latest Developments
Table 75. Diasorin Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 76. Diasorin Infectious Disease Point of Care Diagnostics Product Offered
Table 77. Diasorin Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Diasorin Main Business
Table 79. Diasorin Latest Developments
Table 80. Roche Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 81. Roche Infectious Disease Point of Care Diagnostics Product Offered
Table 82. Roche Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Roche Main Business
Table 84. Roche Latest Developments
Table 85. Danaher Corporation Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 86. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offered
Table 87. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Danaher Corporation Main Business
Table 89. Danaher Corporation Latest Developments
Table 90. BD Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 91. BD Infectious Disease Point of Care Diagnostics Product Offered
Table 92. BD Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. BD Main Business
Table 94. BD Latest Developments
Table 95. Bio-Rad Laboratories Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 96. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offered
Table 97. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Bio-Rad Laboratories Main Business
Table 99. Bio-Rad Laboratories Latest Developments
Table 100. Cavidi Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 101. Cavidi Infectious Disease Point of Care Diagnostics Product Offered
Table 102. Cavidi Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Cavidi Main Business
Table 104. Cavidi Latest Developments
Table 105. Cepheid Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 106. Cepheid Infectious Disease Point of Care Diagnostics Product Offered
Table 107. Cepheid Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cepheid Main Business
Table 109. Cepheid Latest Developments
Table 110. Diaxonhit Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 111. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offered
Table 112. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Diaxonhit Main Business
Table 114. Diaxonhit Latest Developments
Table 115. Eiken Chemical Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 116. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offered
Table 117. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Eiken Chemical Main Business
Table 119. Eiken Chemical Latest Developments
Table 120. EMD Millipore Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 121. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offered
Table 122. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. EMD Millipore Main Business
Table 124. EMD Millipore Latest Developments
Table 125. Epitope Diagnostic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 126. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offered
Table 127. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Epitope Diagnostic Main Business
Table 129. Epitope Diagnostic Latest Developments
Table 130. Euroimmun Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 131. Euroimmun Infectious Disease Point of Care Diagnostics Product Offered
Table 132. Euroimmun Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Euroimmun Main Business
Table 134. Euroimmun Latest Developments
Table 135. Gold Standard Diagnostics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 136. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offered
Table 137. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Gold Standard Diagnostics Main Business
Table 139. Gold Standard Diagnostics Latest Developments
Table 140. Hologic Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 141. Hologic Infectious Disease Point of Care Diagnostics Product Offered
Table 142. Hologic Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hologic Main Business
Table 144. Hologic Latest Developments
Table 145. Immunetics Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 146. Immunetics Infectious Disease Point of Care Diagnostics Product Offered
Table 147. Immunetics Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Immunetics Main Business
Table 149. Immunetics Latest Developments
Table 150. InBios International Details, Company Type, Infectious Disease Point of Care Diagnostics Area Served and Its Competitors
Table 151. InBios International Infectious Disease Point of Care Diagnostics Product Offered
Table 152. InBios International Infectious Disease Point of Care Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. InBios International Main Business
Table 154. InBios International Latest Developments
LIST OF FIGURES
Figure 1. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infectious Disease Point of Care Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infectious Disease Point of Care Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Infectious Disease Point of Care Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2024
Figure 10. Infectious Disease Point of Care Diagnostics in Bacterial Infections
Figure 11. Global Infectious Disease Point of Care Diagnostics Market: Bacterial Infections (2020-2025) & ($ millions)
Figure 12. Infectious Disease Point of Care Diagnostics in Fungal Infection
Figure 13. Global Infectious Disease Point of Care Diagnostics Market: Fungal Infection (2020-2025) & ($ millions)
Figure 14. Infectious Disease Point of Care Diagnostics in Virus Infection
Figure 15. Global Infectious Disease Point of Care Diagnostics Market: Virus Infection (2020-2025) & ($ millions)
Figure 16. Infectious Disease Point of Care Diagnostics in Cardiovascular Infection
Figure 17. Global Infectious Disease Point of Care Diagnostics Market: Cardiovascular Infection (2020-2025) & ($ millions)
Figure 18. Infectious Disease Point of Care Diagnostics in Gastrointestinal Infection
Figure 19. Global Infectious Disease Point of Care Diagnostics Market: Gastrointestinal Infection (2020-2025) & ($ millions)
Figure 20. Infectious Disease Point of Care Diagnostics in Sexually Transmitted Disease (STD) Infection
Figure 21. Global Infectious Disease Point of Care Diagnostics Market: Sexually Transmitted Disease (STD) Infection (2020-2025) & ($ millions)
Figure 22. Infectious Disease Point of Care Diagnostics in Central Nervous System Infection
Figure 23. Global Infectious Disease Point of Care Diagnostics Market: Central Nervous System Infection (2020-2025) & ($ millions)
Figure 24. Infectious Disease Point of Care Diagnostics in Other
Figure 25. Global Infectious Disease Point of Care Diagnostics Market: Other (2020-2025) & ($ millions)
Figure 26. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2024
Figure 27. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player in 2024
Figure 28. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Figure 29. Americas Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 30. APAC Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 31. Europe Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 33. Americas Infectious Disease Point of Care Diagnostics Value Market Share by Country in 2024
Figure 34. United States Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2024
Figure 39. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 40. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 41. China Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. India Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country in 2024
Figure 48. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Germany Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. France Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. APAC Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Europe Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. United States Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Canada Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Mexico Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Brazil Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. China Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Japan Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Korea Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. India Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Australia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Germany Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. France Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 79. UK Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 80. Italy Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 81. Russia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 82. Egypt Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 83. South Africa Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 84. Israel Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 85. Turkey Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 86. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 1. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Infectious Disease Point of Care Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Infectious Disease Point of Care Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Infectious Disease Point of Care Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Type in 2024
Figure 10. Infectious Disease Point of Care Diagnostics in Bacterial Infections
Figure 11. Global Infectious Disease Point of Care Diagnostics Market: Bacterial Infections (2020-2025) & ($ millions)
Figure 12. Infectious Disease Point of Care Diagnostics in Fungal Infection
Figure 13. Global Infectious Disease Point of Care Diagnostics Market: Fungal Infection (2020-2025) & ($ millions)
Figure 14. Infectious Disease Point of Care Diagnostics in Virus Infection
Figure 15. Global Infectious Disease Point of Care Diagnostics Market: Virus Infection (2020-2025) & ($ millions)
Figure 16. Infectious Disease Point of Care Diagnostics in Cardiovascular Infection
Figure 17. Global Infectious Disease Point of Care Diagnostics Market: Cardiovascular Infection (2020-2025) & ($ millions)
Figure 18. Infectious Disease Point of Care Diagnostics in Gastrointestinal Infection
Figure 19. Global Infectious Disease Point of Care Diagnostics Market: Gastrointestinal Infection (2020-2025) & ($ millions)
Figure 20. Infectious Disease Point of Care Diagnostics in Sexually Transmitted Disease (STD) Infection
Figure 21. Global Infectious Disease Point of Care Diagnostics Market: Sexually Transmitted Disease (STD) Infection (2020-2025) & ($ millions)
Figure 22. Infectious Disease Point of Care Diagnostics in Central Nervous System Infection
Figure 23. Global Infectious Disease Point of Care Diagnostics Market: Central Nervous System Infection (2020-2025) & ($ millions)
Figure 24. Infectious Disease Point of Care Diagnostics in Other
Figure 25. Global Infectious Disease Point of Care Diagnostics Market: Other (2020-2025) & ($ millions)
Figure 26. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Application in 2024
Figure 27. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Player in 2024
Figure 28. Global Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Figure 29. Americas Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 30. APAC Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 31. Europe Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2020-2025 ($ millions)
Figure 33. Americas Infectious Disease Point of Care Diagnostics Value Market Share by Country in 2024
Figure 34. United States Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Region in 2024
Figure 39. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 40. APAC Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 41. China Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. India Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Country in 2024
Figure 48. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Germany Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. France Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Infectious Disease Point of Care Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. APAC Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Europe Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. United States Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Canada Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Mexico Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Brazil Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. China Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Japan Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Korea Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. India Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Australia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Germany Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. France Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 79. UK Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 80. Italy Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 81. Russia Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 82. Egypt Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 83. South Africa Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 84. Israel Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 85. Turkey Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
Figure 86. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Infectious Disease Point of Care Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Infectious Disease Point of Care Diagnostics Market Size 2026-2031 ($ millions)
More Publications
Global Urology Drainage Systems Urology Drain Bags Market Growth 2024-2030
US$ 3,660.00
March 2024
92 pages
Global Cryptosporidium Diagnostic Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
99 pages
Global Low-Calorie Sweeteners Market Growth 2025-2031
US$ 3,660.00
March 2025
84 pages
